Procedure Codes in MS-DRG 266 - ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITH MCC
The Medicare Severity Diagnosis-Related Group or MS-DRG is a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). This is the group for Procedure Codes in MS-DRG 266 - ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITH Major Complication or Comorbidity diseases in version MS-DRG V41.0 applicable from 10/01/2023 through 09/30/2024.
| MS-DRG | MS-DRG Title | MCD | Relative Weight | Geometric LOS | Arithmetic LOS |
|---|---|---|---|---|---|
| 266 | ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITH MCC | 05 | 6.2461 Relative Weight The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization. |
6.25 Geometric Length of Stay The geometric mean length of stay (GMLOS) is used by Medicare to calculate the reimbursement for patients whose medical treatment takes a much longer or shorter time than average. |
2.70 Arithmetic Length of Stay The average length of stay (ALOS) reflects the average number of days a patient spends in a hospital for each admission. |
ICD-10-PCS Codes in Diagnostic Related Group
- 02RF
- 02RF37H Replacement of Aortic Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach
- 02RF37Z Replacement of Aortic Valve with Autologous Tissue Substitute, Percutaneous Approach
- 02RF38H Replacement of Aortic Valve with Zooplastic Tissue, Transapical, Percutaneous Approach
- 02RF38N Replacement of Aortic Valve with Zooplastic Tissue, using Rapid Deployment Technique, Percutaneous Approach
- 02RF38Z Replacement of Aortic Valve with Zooplastic Tissue, Percutaneous Approach
- 02RF3JH Replacement of Aortic Valve with Synthetic Substitute, Transapical, Percutaneous Approach
- 02RF3JZ Replacement of Aortic Valve with Synthetic Substitute, Percutaneous Approach
- 02RF3KH Replacement of Aortic Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach
- 02RF3KZ Replacement of Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Approach
- 02RG
- 02RG37H Replacement of Mitral Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach
- 02RG37Z Replacement of Mitral Valve with Autologous Tissue Substitute, Percutaneous Approach
- 02RG38H Replacement of Mitral Valve with Zooplastic Tissue, Transapical, Percutaneous Approach
- 02RG38Z Replacement of Mitral Valve with Zooplastic Tissue, Percutaneous Approach
- 02RG3JH Replacement of Mitral Valve with Synthetic Substitute, Transapical, Percutaneous Approach
- 02RG3JZ Replacement of Mitral Valve with Synthetic Substitute, Percutaneous Approach
- 02RG3KH Replacement of Mitral Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach
- 02RG3KZ Replacement of Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Approach
- 02RH
- 02RH37H Replacement of Pulmonary Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach
- 02RH37Z Replacement of Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Approach
- 02RH38H Replacement of Pulmonary Valve with Zooplastic Tissue, Transapical, Percutaneous Approach
- 02RH38L Replacement of Pulmonary Valve with Zooplastic Tissue, In Existing Conduit, Percutaneous Approach
- 02RH38M Replacement of Pulmonary Valve with Zooplastic Tissue, Native Site, Percutaneous Approach
- 02RH38Z Replacement of Pulmonary Valve with Zooplastic Tissue, Percutaneous Approach
- 02RH3JH Replacement of Pulmonary Valve with Synthetic Substitute, Transapical, Percutaneous Approach
- 02RH3JZ Replacement of Pulmonary Valve with Synthetic Substitute, Percutaneous Approach
- 02RH3KH Replacement of Pulmonary Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach
- 02RH3KZ Replacement of Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Approach
- 02RJ
- 02RJ37H Replacement of Tricuspid Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach
- 02RJ37Z Replacement of Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Approach
- 02RJ38H Replacement of Tricuspid Valve with Zooplastic Tissue, Transapical, Percutaneous Approach
- 02RJ38Z Replacement of Tricuspid Valve with Zooplastic Tissue, Percutaneous Approach
- 02RJ3JH Replacement of Tricuspid Valve with Synthetic Substitute, Transapical, Percutaneous Approach
- 02RJ3JZ Replacement of Tricuspid Valve with Synthetic Substitute, Percutaneous Approach
- 02RJ3KH Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach
- 02RJ3KZ Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Approach
- 02UF
- 02UF37J Supplement Aortic Valve created from Truncal Valve with Autologous Tissue Substitute, Percutaneous Approach
- 02UF37Z Supplement Aortic Valve with Autologous Tissue Substitute, Percutaneous Approach
- 02UF38J Supplement Aortic Valve created from Truncal Valve with Zooplastic Tissue, Percutaneous Approach
- 02UF38Z Supplement Aortic Valve with Zooplastic Tissue, Percutaneous Approach
- 02UF3JJ Supplement Aortic Valve created from Truncal Valve with Synthetic Substitute, Percutaneous Approach
- 02UF3JZ Supplement Aortic Valve with Synthetic Substitute, Percutaneous Approach
- 02UF3KJ Supplement Aortic Valve created from Truncal Valve with Nonautologous Tissue Substitute, Percutaneous Approach
- 02UF3KZ Supplement Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Approach
- 02UG
- 02UG37E Supplement Mitral Valve created from Left Atrioventricular Valve with Autologous Tissue Substitute, Percutaneous Approach
- 02UG37Z Supplement Mitral Valve with Autologous Tissue Substitute, Percutaneous Approach
- 02UG38E Supplement Mitral Valve created from Left Atrioventricular Valve with Zooplastic Tissue, Percutaneous Approach
- 02UG38Z Supplement Mitral Valve with Zooplastic Tissue, Percutaneous Approach
- 02UG3JE Supplement Mitral Valve created from Left Atrioventricular Valve with Synthetic Substitute, Percutaneous Approach
- 02UG3JH Supplement Mitral Valve with Synthetic Substitute, Transapical, Percutaneous Approach
- 02UG3JZ Supplement Mitral Valve with Synthetic Substitute, Percutaneous Approach
- 02UG3KE Supplement Mitral Valve created from Left Atrioventricular Valve with Nonautologous Tissue Substitute, Percutaneous Approach
- 02UG3KZ Supplement Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Approach
- 02UH
- 02UH37Z Supplement Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Approach
- 02UH38Z Supplement Pulmonary Valve with Zooplastic Tissue, Percutaneous Approach
- 02UH3JZ Supplement Pulmonary Valve with Synthetic Substitute, Percutaneous Approach
- 02UH3KZ Supplement Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Approach
- 02UJ
- 02UJ37G Supplement Tricuspid Valve created from Right Atrioventricular Valve with Autologous Tissue Substitute, Percutaneous Approach
- 02UJ37Z Supplement Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Approach
- 02UJ38G Supplement Tricuspid Valve created from Right Atrioventricular Valve with Zooplastic Tissue, Percutaneous Approach
- 02UJ38Z Supplement Tricuspid Valve with Zooplastic Tissue, Percutaneous Approach
- 02UJ3JG Supplement Tricuspid Valve created from Right Atrioventricular Valve with Synthetic Substitute, Percutaneous Approach
- 02UJ3JZ Supplement Tricuspid Valve with Synthetic Substitute, Percutaneous Approach
- 02UJ3KG Supplement Tricuspid Valve created from Right Atrioventricular Valve with Nonautologous Tissue Substitute, Percutaneous Approach
- 02UJ3KZ Supplement Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Approach